Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Fons Michael
 2. Date of Event Requiring Statement (Month/Day/Year)
08/21/2007		 3. Issuer Name and Ticker or Trading Symbol
INOVIO BIOMEDICAL CORP [INO]
(Last)
(First)
(Middle)
11494 SORRENTO VALLEY RD		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
VP, Corporate Development
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

SAN DIEGO, CA 92121		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Inovio Biomedical Corporation Common Stock 25
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Inovio Biomedical Corporation Common Stock Option 08/23/2007 06/17/2014 Inovio Biomedical Corporation Common Stock 37,500 $ 5.32 D  
Inovio Biomedical Corporation Common Stock Option 08/23/2007(1) 03/23/2016 Inovio Biomedical Corporation Common Stock 20,000 $ 2.45 D  
Inovio Biomedical Corporation Common Stock Option 08/23/2007(2) 03/08/2017 Inovio Biomedical Corporation Common Stock 20,000 $ 3.16 D  
Inovio Biomedical Corporation Common Stock Option 08/23/2007(3) 05/03/2017 Inovio Biomedical Corporation Common Stock 25,000 $ 3.75 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Fons Michael
11494 SORRENTO VALLEY RD
SAN DIEGO, CA 92121		       VP, Corporate Development  

Signatures

Michael Fons 08/23/2007
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Of the 20,000 common stock options outstanding; 10,000 are exercisable on 8/23/07; 5,000 are exercisable on 3/23/08; and 5,000 are exercisable on 3/23/09.
(2) Of the 20,000 common stock options outstanding; 5,000 are exercisable on 8/23/07; 5,000 are exercisable on 3/8/2008; 5,000 are exercisable on 3/8/09; and 5,000 are exercisable on 3/8/10.
(3) Of the 25,000 common stock options outstanding; 6,250 are exercisable on 8/23/07; 6,250 are exercisable on 5/3/08; 6,250 are exercisable on 5/3/09; and 6,250 are exercisable on 5/3/10.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.